Click for best price
Cardiac Biomarkers Market Size, Share 2024
| Market size in 2023 |
US$ 664.2 million
|
Forecast Market size by 2030 |
US$ 1272.1 million
|
| Growth Rate |
CAGR of 9.7% |
Number of Pages |
108 Pages |
This research report provides a comprehensive analysis of the Cardiac Biomarkers market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cardiac Biomarkers market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cardiac Biomarkers, challenges faced by the industry, and potential opportunities for market players.
The global Cardiac Biomarkers market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cardiac Biomarkers market presents opportunities for various stakeholders, including Acute Coronary Syndrome, Myocardial Infarction. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cardiac Biomarkers market. Additionally, the growing consumer demand present avenues for market expansion.
The global Cardiac Biomarkers market was valued at US$ 664.2 million in 2023 and is projected to reach US$ 1272.1 million by 2030, at a CAGR of 9.7% during the forecast period.
The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with heart.?Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. Cardiac biomarkers market has witnessed a greater demand over the past five to six years.?
Key Features:
The research report on the Cardiac Biomarkers market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cardiac Biomarkers market.
Market Overview: The report provides a comprehensive overview of the Cardiac Biomarkers market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Troponin, CK-MB), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cardiac Biomarkers market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cardiac Biomarkers market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cardiac Biomarkers market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cardiac Biomarkers market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cardiac Biomarkers market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cardiac Biomarkers market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cardiac Biomarkers, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cardiac Biomarkers market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cardiac Biomarkers market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Troponin
CK-MB
Natriuretic Peptides - BNP and NT-proBNP
Myoglobin
Others
Market segment by Application
Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others
Global Cardiac Biomarkers Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Abbott
Abbott
F. Hoffmann-La Roche
Advanced ImmunoChemical
AgPlus Diagnostics
BG Medicine
BioLegend
bioM?rieux
Bio-Rad Laboratories
BODITECH MED
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cardiac Biomarkers, market overview.
Chapter 2: Global Cardiac Biomarkers market size in revenue.
Chapter 3: Detailed analysis of Cardiac Biomarkers company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardiac Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cardiac Biomarkers Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 664.2 million
|
| Forecast Market size by 2030 |
US$ 1272.1 million
|
| Growth Rate |
CAGR of 9.7% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
108 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cardiac Biomarkers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cardiac Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cardiac Biomarkers Overall Market Size
2.1 Global Cardiac Biomarkers Market Size: 2023 VS 2030
2.2 Global Cardiac Biomarkers Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cardiac Biomarkers Players in Global Market
3.2 Top Global Cardiac Biomarkers Companies Ranked by Revenue
3.3 Global Cardiac Biomarkers Revenue by Companies
3.4 Top 3 and Top 5 Cardiac Biomarkers Companies in Global Market, by Revenue in 2023
3.5 Global Companies Cardiac Biomarkers Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cardiac Biomarkers Players in Global Market
3.6.1 List of Global Tier 1 Cardiac Biomarkers Companies
3.6.2 List of Global Tier 2 and Tier 3 Cardiac Biomarkers Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cardiac Biomarkers Market Size Markets, 2023 & 2030
4.1.2 Troponin
4.1.3 CK-MB
4.1.4 Natriuretic Peptides - BNP and NT-proBNP
4.1.5 Myoglobin
4.1.6 Others
4.2 By Type - Global Cardiac Biomarkers Revenue & Forecasts
4.2.1 By Type - Global Cardiac Biomarkers Revenue, 2019-2024
4.2.2 By Type - Global Cardiac Biomarkers Revenue, 2025-2030
4.2.3 By Type - Global Cardiac Biomarkers Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cardiac Biomarkers Market Size, 2023 & 2030
5.1.2 Acute Coronary Syndrome
5.1.3 Myocardial Infarction
5.1.4 Congestive Heart Failure
5.1.5 Others
5.2 By Application - Global Cardiac Biomarkers Revenue & Forecasts
5.2.1 By Application - Global Cardiac Biomarkers Revenue, 2019-2024
5.2.2 By Application - Global Cardiac Biomarkers Revenue, 2025-2030
5.2.3 By Application - Global Cardiac Biomarkers Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Cardiac Biomarkers Market Size, 2023 & 2030
6.2 By Region - Global Cardiac Biomarkers Revenue & Forecasts
6.2.1 By Region - Global Cardiac Biomarkers Revenue, 2019-2024
6.2.2 By Region - Global Cardiac Biomarkers Revenue, 2025-2030
6.2.3 By Region - Global Cardiac Biomarkers Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Cardiac Biomarkers Revenue, 2019-2030
6.3.2 US Cardiac Biomarkers Market Size, 2019-2030
6.3.3 Canada Cardiac Biomarkers Market Size, 2019-2030
6.3.4 Mexico Cardiac Biomarkers Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Cardiac Biomarkers Revenue, 2019-2030
6.4.2 Germany Cardiac Biomarkers Market Size, 2019-2030
6.4.3 France Cardiac Biomarkers Market Size, 2019-2030
6.4.4 U.K. Cardiac Biomarkers Market Size, 2019-2030
6.4.5 Italy Cardiac Biomarkers Market Size, 2019-2030
6.4.6 Russia Cardiac Biomarkers Market Size, 2019-2030
6.4.7 Nordic Countries Cardiac Biomarkers Market Size, 2019-2030
6.4.8 Benelux Cardiac Biomarkers Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Cardiac Biomarkers Revenue, 2019-2030
6.5.2 China Cardiac Biomarkers Market Size, 2019-2030
6.5.3 Japan Cardiac Biomarkers Market Size, 2019-2030
6.5.4 South Korea Cardiac Biomarkers Market Size, 2019-2030
6.5.5 Southeast Asia Cardiac Biomarkers Market Size, 2019-2030
6.5.6 India Cardiac Biomarkers Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Cardiac Biomarkers Revenue, 2019-2030
6.6.2 Brazil Cardiac Biomarkers Market Size, 2019-2030
6.6.3 Argentina Cardiac Biomarkers Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cardiac Biomarkers Revenue, 2019-2030
6.7.2 Turkey Cardiac Biomarkers Market Size, 2019-2030
6.7.3 Israel Cardiac Biomarkers Market Size, 2019-2030
6.7.4 Saudi Arabia Cardiac Biomarkers Market Size, 2019-2030
6.7.5 UAE Cardiac Biomarkers Market Size, 2019-2030
7 Cardiac Biomarkers Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Cardiac Biomarkers Major Product Offerings
7.1.4 Abbott Cardiac Biomarkers Revenue in Global Market (2019-2024)
7.1.5 Abbott Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Cardiac Biomarkers Major Product Offerings
7.2.4 Abbott Cardiac Biomarkers Revenue in Global Market (2019-2024)
7.2.5 Abbott Key News & Latest Developments
7.3 F. Hoffmann-La Roche
7.3.1 F. Hoffmann-La Roche Company Summary
7.3.2 F. Hoffmann-La Roche Business Overview
7.3.3 F. Hoffmann-La Roche Cardiac Biomarkers Major Product Offerings
7.3.4 F. Hoffmann-La Roche Cardiac Biomarkers Revenue in Global Market (2019-2024)
7.3.5 F. Hoffmann-La Roche Key News & Latest Developments
7.4 Advanced ImmunoChemical
7.4.1 Advanced ImmunoChemical Company Summary
7.4.2 Advanced ImmunoChemical Business Overview
7.4.3 Advanced ImmunoChemical Cardiac Biomarkers Major Product Offerings
7.4.4 Advanced ImmunoChemical Cardiac Biomarkers Revenue in Global Market (2019-2024)
7.4.5 Advanced ImmunoChemical Key News & Latest Developments
7.5 AgPlus Diagnostics
7.5.1 AgPlus Diagnostics Company Summary
7.5.2 AgPlus Diagnostics Business Overview
7.5.3 AgPlus Diagnostics Cardiac Biomarkers Major Product Offerings
7.5.4 AgPlus Diagnostics Cardiac Biomarkers Revenue in Global Market (2019-2024)
7.5.5 AgPlus Diagnostics Key News & Latest Developments
7.6 BG Medicine
7.6.1 BG Medicine Company Summary
7.6.2 BG Medicine Business Overview
7.6.3 BG Medicine Cardiac Biomarkers Major Product Offerings
7.6.4 BG Medicine Cardiac Biomarkers Revenue in Global Market (2019-2024)
7.6.5 BG Medicine Key News & Latest Developments
7.7 BioLegend
7.7.1 BioLegend Company Summary
7.7.2 BioLegend Business Overview
7.7.3 BioLegend Cardiac Biomarkers Major Product Offerings
7.7.4 BioLegend Cardiac Biomarkers Revenue in Global Market (2019-2024)
7.7.5 BioLegend Key News & Latest Developments
7.8 bioM?rieux
7.8.1 bioM?rieux Company Summary
7.8.2 bioM?rieux Business Overview
7.8.3 bioM?rieux Cardiac Biomarkers Major Product Offerings
7.8.4 bioM?rieux Cardiac Biomarkers Revenue in Global Market (2019-2024)
7.8.5 bioM?rieux Key News & Latest Developments
7.9 Bio-Rad Laboratories
7.9.1 Bio-Rad Laboratories Company Summary
7.9.2 Bio-Rad Laboratories Business Overview
7.9.3 Bio-Rad Laboratories Cardiac Biomarkers Major Product Offerings
7.9.4 Bio-Rad Laboratories Cardiac Biomarkers Revenue in Global Market (2019-2024)
7.9.5 Bio-Rad Laboratories Key News & Latest Developments
7.10 BODITECH MED
7.10.1 BODITECH MED Company Summary
7.10.2 BODITECH MED Business Overview
7.10.3 BODITECH MED Cardiac Biomarkers Major Product Offerings
7.10.4 BODITECH MED Cardiac Biomarkers Revenue in Global Market (2019-2024)
7.10.5 BODITECH MED Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cardiac Biomarkers Market Opportunities & Trends in Global Market
Table 2. Cardiac Biomarkers Market Drivers in Global Market
Table 3. Cardiac Biomarkers Market Restraints in Global Market
Table 4. Key Players of Cardiac Biomarkers in Global Market
Table 5. Top Cardiac Biomarkers Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Cardiac Biomarkers Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Cardiac Biomarkers Revenue Share by Companies, 2019-2024
Table 8. Global Companies Cardiac Biomarkers Product Type
Table 9. List of Global Tier 1 Cardiac Biomarkers Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cardiac Biomarkers Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Cardiac Biomarkers Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Cardiac Biomarkers Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Cardiac Biomarkers Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Cardiac Biomarkers Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Cardiac Biomarkers Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Cardiac Biomarkers Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Cardiac Biomarkers Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Cardiac Biomarkers Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Cardiac Biomarkers Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Cardiac Biomarkers Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Cardiac Biomarkers Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Cardiac Biomarkers Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Cardiac Biomarkers Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Cardiac Biomarkers Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Cardiac Biomarkers Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Cardiac Biomarkers Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Cardiac Biomarkers Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Cardiac Biomarkers Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Cardiac Biomarkers Revenue, (US$, Mn), 2025-2030
Table 30. Abbott Company Summary
Table 31. Abbott Cardiac Biomarkers Product Offerings
Table 32. Abbott Cardiac Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 33. Abbott Key News & Latest Developments
Table 34. Abbott Company Summary
Table 35. Abbott Cardiac Biomarkers Product Offerings
Table 36. Abbott Cardiac Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 37. Abbott Key News & Latest Developments
Table 38. F. Hoffmann-La Roche Company Summary
Table 39. F. Hoffmann-La Roche Cardiac Biomarkers Product Offerings
Table 40. F. Hoffmann-La Roche Cardiac Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 41. F. Hoffmann-La Roche Key News & Latest Developments
Table 42. Advanced ImmunoChemical Company Summary
Table 43. Advanced ImmunoChemical Cardiac Biomarkers Product Offerings
Table 44. Advanced ImmunoChemical Cardiac Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 45. Advanced ImmunoChemical Key News & Latest Developments
Table 46. AgPlus Diagnostics Company Summary
Table 47. AgPlus Diagnostics Cardiac Biomarkers Product Offerings
Table 48. AgPlus Diagnostics Cardiac Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 49. AgPlus Diagnostics Key News & Latest Developments
Table 50. BG Medicine Company Summary
Table 51. BG Medicine Cardiac Biomarkers Product Offerings
Table 52. BG Medicine Cardiac Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 53. BG Medicine Key News & Latest Developments
Table 54. BioLegend Company Summary
Table 55. BioLegend Cardiac Biomarkers Product Offerings
Table 56. BioLegend Cardiac Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 57. BioLegend Key News & Latest Developments
Table 58. bioM?rieux Company Summary
Table 59. bioM?rieux Cardiac Biomarkers Product Offerings
Table 60. bioM?rieux Cardiac Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 61. bioM?rieux Key News & Latest Developments
Table 62. Bio-Rad Laboratories Company Summary
Table 63. Bio-Rad Laboratories Cardiac Biomarkers Product Offerings
Table 64. Bio-Rad Laboratories Cardiac Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 65. Bio-Rad Laboratories Key News & Latest Developments
Table 66. BODITECH MED Company Summary
Table 67. BODITECH MED Cardiac Biomarkers Product Offerings
Table 68. BODITECH MED Cardiac Biomarkers Revenue (US$, Mn) & (2019-2024)
Table 69. BODITECH MED Key News & Latest Developments
List of Figures
Figure 1. Cardiac Biomarkers Segment by Type in 2023
Figure 2. Cardiac Biomarkers Segment by Application in 2023
Figure 3. Global Cardiac Biomarkers Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Cardiac Biomarkers Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Cardiac Biomarkers Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cardiac Biomarkers Revenue in 2023
Figure 8. By Type - Global Cardiac Biomarkers Revenue Market Share, 2019-2030
Figure 9. By Application - Global Cardiac Biomarkers Revenue Market Share, 2019-2030
Figure 10. By Type - Global Cardiac Biomarkers Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Cardiac Biomarkers Revenue Market Share, 2019-2030
Figure 12. By Application - Global Cardiac Biomarkers Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Cardiac Biomarkers Revenue Market Share, 2019-2030
Figure 14. By Region - Global Cardiac Biomarkers Revenue Market Share, 2019-2030
Figure 15. By Country - North America Cardiac Biomarkers Revenue Market Share, 2019-2030
Figure 16. US Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Cardiac Biomarkers Revenue Market Share, 2019-2030
Figure 20. Germany Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 21. France Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Cardiac Biomarkers Revenue Market Share, 2019-2030
Figure 28. China Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 32. India Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Cardiac Biomarkers Revenue Market Share, 2019-2030
Figure 34. Brazil Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Cardiac Biomarkers Revenue Market Share, 2019-2030
Figure 37. Turkey Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Cardiac Biomarkers Revenue, (US$, Mn), 2019-2030
Figure 41. Abbott Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Abbott Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. F. Hoffmann-La Roche Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Advanced ImmunoChemical Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. AgPlus Diagnostics Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. BG Medicine Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. BioLegend Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. bioM?rieux Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Bio-Rad Laboratories Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. BODITECH MED Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
